MetaCap

ADARx Pharmaceuticals (ADRX) vs AnaptysBio (ANAB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

ADARx Pharmaceuticals is the larger company by market cap ($1.42 billion vs $1.39 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ADRX-33.90%ANAB-8.57%
+9%-14%-36%
Sep 25, 20261 yearNov 20, 2026
ADRX-33.90%ANAB-8.57%
+2%-17%-36%
Sep 21, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ADRX versus ANAB key metrics
MetricADRXANAB
Share price$12.79$46.63
Market cap$1.42B$1.39B
1-day change-9.68%-1.62%
YTD return—+44.28%
1-year return—+76.58%
5-year return—+124.76%
P/E ratio (TTM)—7.15
Forward P/E—8.66
EPS (TTM)$-6.75$6.52
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$234.60M
Revenue growth (YoY)—+157.01%
Net income (latest FY)—$-13.23M
Operating margin—96.72%
Net margin—-5.64%
52-week high$23.21$72.36
52-week low$12.50$26.01
Distance from 52-week high-44.89%-35.56%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+167.79%+87.11%
Average volume650.63K496.92K
Shares outstanding111.19M29.73M
Employees100—
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About ADARx Pharmaceuticals

ADRX stock →

ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees

About AnaptysBio

ANAB stock →

AnaptysBio, Inc. discovers and out-licenses therapeutic bodies in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations

ADRX vs ANAB FAQ

Which is bigger, ADARx Pharmaceuticals or AnaptysBio?

ADARx Pharmaceuticals (ADRX) is larger, with a market capitalization of $1.42B compared with $1.39B for AnaptysBio (ANAB).

Are ADARx Pharmaceuticals and AnaptysBio in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons